[Cytokine determination. Diagnostic significance from the clinical and immunological viewpoint]

Effectiveness, safety and quality-of-life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non-interventional, prospective, German multicentre PERSIST study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023

Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023

Real-world evidence from the non-interventional, prospective, German multicentre PERSIST study of patients with psoriasis after 1 year of treatment with guselkumab.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022

Personalized risk prediction of postoperative cognitive impairment - rationale for the EU-funded BioCog project.

European psychiatry : the journal of the Association of European Psychiatrists·2018

Interleukin-10 receptor-1 expression in monocyte-derived antigen-presenting cell populations: dendritic cells partially escape from IL-10's inhibitory mechanisms.

Genes and immunity·2014

Cross-validation of IFN-γ Elispot assay for measuring alloreactive memory/effector T cell responses in renal transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013